The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPUR.L Regulatory News (PUR)

  • There is currently no data for PUR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Directorat

24 Jun 2008 07:00

RNS Number : 3633X
Pure Wafer PLC
24 June 2008
 



24th June 2008

Pure Wafer plc

("Pure Wafer" or the "Company")

Trading Update and Directorate Change

Swansea based Pure Wafer plc, the provider of high quality silicon wafer reclaim services for many of the world's leading semiconductor manufacturers, would like to update the market on its trading expectation for the financial year to 30th June 2008.

The Board reported with its interim results that our customers were experiencing severe trading conditions as the semiconductor industry continues its prolonged recession, which together with new competition in Taiwan, has resulted in price pressure for its services.

The deterioration of the semiconductor industry has accelerated during the second half of the financial period, during which the company has experienced a reduction in its volume of business in the last quarter of the financial year to date as customers reduce their reclaim wafer inventories by de-stocking as part of their response to reduce their substantial trading losses. 

Management have taken action to increase sales volumes which has resulted in an expected improvement in trading in June, with an increase in volumes, however it is too early to tell if this demonstrates a sustained upturn.

Cost reduction activities undertaken by the Company to offset falling selling prices have taken place during the period and these will be fully realised during financial year 2009. 

The ramp up of 300mm capability into our US plant has been slower than expected due to the industry slowdown. Qualification is underway with all major US customers however the pace of these qualifications has been slowed at the customer sites due to them prioritising other engineering activities.

This recent reduction in volume business together with the continued downward pressure on selling prices has had an adverse affect on trading performance. As a result the Board expects turnover to be approximately £21.0 million resulting in an EBITDA of £3.5 million and loss before tax of £0.15 million for the financial year to 30 June 2008.

When last tested the Board was within its banking covenants however based on the revised expected outturn for the year the Board would expect these covenants to be breached for the period to 30th June 2008. The Board is in active discussions with its bankers regarding renegotiating these covenants going forwards and believes that the bank remain supportive of the business.

The board also announces that Paul Dolan has stepped down as Interim Group Finance Director with immediate effect and has been replaced by Stephen Young on the board as Interim Group Finance Director. Stephen has been with the business as interim UK finance director since 14th April 2008 and is a chartered management accountant (CIMA) and an experienced public company finance director whose previous position was with British Biocell International (formerly BBI Holdings plc) from August 2001.

The following information is provided in compliance with the provisions of Rule 17 of the AIM Rules:

Director Name: Stephen Michael Young, aged 45

Directorships held during the past five years:

Alchemy Laboratories Limited

British Biocell International Limited

Qnostics Limited

There are no further disclosures to be made in respect of Mr Young under the provisions of paragraph g of Schedule Two of the AIM Rules for Companies.

Pure Wafer

Peter Harrington/Giles Clarke 

Tel: +44 (0)1792 311200

 

 

Altium

Tel: +44 (0)161 831 9133

Phil Adams/Paul Lines

 

 

 

FD

Tel: +44 (0)20 7831 3113

Billy Clegg/Ed Westropp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSAVRWVRNURR
Date   Source Headline
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20234:40 pmRNSSecond Price Monitoring Extn
7th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20232:05 pmRNSSecond Price Monitoring Extn
7th Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
27th Jan 20239:00 amRNSPrice Monitoring Extension
23rd Jan 20235:31 pmRNSCorrection - Notice of Intent to Delist from LSE
23rd Jan 20237:00 amRNSNotice of Intent to Delist from LSE
7th Dec 202211:05 amRNSSecond Price Monitoring Extn
7th Dec 202211:00 amRNSPrice Monitoring Extension
15th Nov 20228:01 amRNS3rd Quarter Results
11th Nov 20227:00 amRNSCourt Approval of Solicitation Process and Relief
2nd Nov 20227:00 amRNSTransfer of Listing from the TSX-V to the NEX
1st Nov 20222:05 pmRNSSecond Price Monitoring Extn
1st Nov 20222:00 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSPureGold Obtains CCAA Protection
31st Oct 20227:00 amRNSApplication for Initial Order for CCAA Protection
26th Oct 20229:05 amRNSSecond Price Monitoring Extn
26th Oct 20229:00 amRNSPrice Monitoring Extension
24th Oct 20224:40 pmRNSSecond Price Monitoring Extn
24th Oct 20224:35 pmRNSPrice Monitoring Extension
24th Oct 20229:05 amRNSSecond Price Monitoring Extn
24th Oct 20229:00 amRNSPrice Monitoring Extension
24th Oct 20227:00 amRNSPureGold Provides Financial and Operations Update
6th Oct 20224:27 pmRNSCorrection: Q3 Production and 4th Quarter Outlook
6th Oct 20227:03 amRNSQ3 Production Results and Fourth Quarter Outlook
26th Sep 20227:00 amRNSTechnical Report with Updated Mineral Resource
12th Sep 20227:00 amRNSRecord Gold Production; Reaffirms Q3 2022 Guidance
16th Aug 20227:00 amRNSOperations Update and Q2 2022 Financial Results
10th Aug 20227:00 amRNSUpdated Mineral Resource Estimate
12th Jul 20227:00 amRNSUS$6M Credit Facility & Strategic Review Process
20th Jun 20224:41 pmRNSSecond Price Monitoring Extn
20th Jun 20224:35 pmRNSPrice Monitoring Extension
15th Jun 20222:05 pmRNSGranting of Stock Options
6th Jun 202211:05 amRNSSecond Price Monitoring Extn
6th Jun 202211:00 amRNSPrice Monitoring Extension
6th Jun 20227:00 amRNSPDMR Unit Dealing
30th May 20227:00 amRNSFinal Tranche of Non-Brokered Private Placement
27th May 20222:56 pmRNSSecurities for Debt Transaction
27th May 20222:48 pmRNSFirst Tranche of Private Placement Closed
20th May 20227:01 amRNSAnticipated Closing Date of Private Placement
18th May 20222:22 pmRNSFirst Quarter Results
13th May 20227:00 amRNSExtension of Waiver Period by Sprott
9th May 20227:00 amRNSC$30 Million Non-Brokered Private Placement
22nd Apr 20224:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:36 pmRNSPrice Monitoring Extension
22nd Apr 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.